This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Cancer Research Technology Limited, Ionctura Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zoë Johnson: Inventor in Pharmaceutical Innovation.
Introduction
Zoë Johnson is an inventor associated with Geneva, Switzerland, and pharmaceutical research. Her patent work concerns a PI3K-δ inhibitor intended for treatment regimens addressing diseases in which the PI3Kδ pathway is pathologically implicated.
Latest Patents
Johnson is associated with 1 patent: “PI3K-δ inhibitor for use in treatment regimens.” The patent describes a compound, or a pharmaceutically acceptable salt of the compound, for treating conditions such as cancer and inflammatory or autoimmune diseases. It specifies a dose and reports a favorable safety profile in humans, particularly regarding hepatotoxicity, diarrhea or colitis, respiratory infections, and hematologic toxicities.
Career Highlights
Johnson’s listed company affiliations include Ionctura SA and Ionctura BV. Her patent work reflects a focus on developing treatment approaches involving the PI3Kδ pathway.
Collaborations
Her listed coworkers include Catherine Pickering and Lars Van Der Veen, reflecting collaborative connections in her professional work.
Conclusion
Zoë Johnson’s patent activity centers on a PI3K-δ inhibitor and its potential use in treatment regimens, highlighting her contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile